Low Dose of Ti 3 C 2 MXene Quantum Dots Mitigate SARS‐CoV‐2 Infection
Small Methods · 2023
DOI: 10.1002/smtd.202300044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2023. Verfasst von Açelya Yilmazer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Ankara University, Golbasi, Ankara, 06830, Turkey. Hauptthemen laut MEDLINE: COVID-19, Quantum Dots. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu, Canadian Institutes of Health Research.
Abstract (Originalsprache)
MXene QDs (MQDs) have been effectively used in several fields of biomedical research. Considering the role of hyperactivation of immune system in infectious diseases, especially in COVID‐19, MQDs stand as a potential candidate as a nanotherapeutic against viral infections. However, the efficacy of MQDs against SARS‐CoV‐2 infection has not been tested yet. In this study, Ti 3 C 2 MQDs are synthesized and their potential in mitigating SARS‐CoV‐2 infection is investigated. Physicochemical characterization suggests that MQDs are enriched with abundance of bioactive functional groups such as oxygen, hydrogen, fluorine, and chlorine groups as well as surface titanium oxides. The efficacy of MQDs is tested in VeroE6 cells infected with SARS‐CoV‐2. These data demonstrate that the treatment with MQDs is able to mitigate multiplication of virus particles, only at very low doses such as 0,15 µg mL −1 . Furthermore, to understand the mechanisms of MQD‐mediated anti‐COVID properties, global proteomics analysis are performed and determined differentially expressed proteins between MQD‐treated and untreated cells. Data reveal that MQDs interfere with the viral life cycle through different mechanisms including the Ca 2 + signaling pathway, IFN‐ α response, virus internalization, replication, and translation. These findings suggest that MQDs can be employed to develop future immunoengineering‐based nanotherapeutics strategies against SARS‐CoV‐2 and other viral infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Ankara University, Golbasi, Ankara, 06830, Turkey.
- Stem Cell Institute, Ankara University, Balgat, Ankara, 06520, Turkey.
- Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, R3T 2N2, Canada.
- Microbiology References Laboratory, Ministry of Health General Directorate of Public Health, Ankara, 06100, Turkey.
- Department of Medical Genetics, Faculty of Medicine, Yuksek Ihtisas University, Ankara, 06530, Turkey.
- Department of Biomedical Sciences, University of Padua, Padua, 35122, Italy.
ORCID-Profile: Açelya Yilmazer
Förderung
- CIHR
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Yilmazer, A., Alagarsamy, K. N., Gokce, C., Summak, G. Y., Rafieerad, A., Bayrakdar, F., Ozturk, B. I., Aktuna, S., Delogu, L. G., Unal, M. A., & Dhingra, S. (2023). Low Dose of Ti 3 C 2 MXene Quantum Dots Mitigate SARS‐CoV‐2 Infection. Small Methods. https://doi.org/10.1002/smtd.202300044
Vancouver
Yilmazer A, Alagarsamy KN, Gokce C, Summak GY, Rafieerad A, Bayrakdar F, et al. Low Dose of Ti 3 C 2 MXene Quantum Dots Mitigate SARS‐CoV‐2 Infection. Small Methods. 2023. doi:10.1002/smtd.202300044
BibTeX
@article{Yilmazer2023,
author = {Yilmazer, Açelya and Alagarsamy, Keshav Narayan and Gokce, Cemile and Summak, Gokce Yagmur and Rafieerad, Alireza and Bayrakdar, Fatma and Ozturk, Berfin Ilayda and Aktuna, Suleyman and Delogu, Lucia Gemma and Unal, Mehmet Altay and Dhingra, Sanjiv},
title = {Low Dose of Ti 3 C 2 MXene Quantum Dots Mitigate SARS‐CoV‐2 Infection},
journal = {Small Methods},
year = {2023},
doi = {10.1002/smtd.202300044}
}
EUVIMED